Journal of Ayurveda and Integrated Medical Sciences

2025 Volume 10 Number 9 September
Publisherwww.maharshicharaka.in

Efficacy of Single Drug Therapy in the management of Subclinical Hypothyroidism: A Case Series analysis using Ayurvedic approach

Koundalkar SD1*, Chougale A2, Dalal D3
DOI:10.21760/jaims.10.9.61

1* Shubham Dulaji Koundalkar, Assistant Professor, Dept of Dravyaguna, Shri Shivayogeeshwara Rural Ayurvedic Medical College, Inchal, Karnataka, India.

2 Arun Chougale, Professor and HOD, Dept of Dravyaguna, Shri B M Kankanwadi Ayurveda Mahavidyalaya, Shahapur Belagavi, Karnataka, India.

3 Dimple Dalal, Final Year Post Graduate Scholar, Dept of Panchakarma, Shri B M Kankanwadi Ayurveda Mahavidyalaya, Shahapur Belagavi, Karnataka, India.

Subclinical hypothyroidism (SCH) is characterized by elevated thyroid-stimulating hormone (TSH) levels with normal free thyroxine (T4) levels. Herbal formulations used in Ayurvedic medicine offer a comprehensive strategy that may be beneficial to controlling symptoms than conventional treatment, which usually concentrate on hormone replacement. This case series aims to determine the effectiveness of single drug therapy in treating Subclinical Hypothyroidism, with a focus toward evaluating biochemical markers and clinical outcomes which is need of the hour. A total of 8 patients diagnosed with subclinical hypothyroidism were treated with Shigru Patra Churna tablet over 42 days. Patient information was gathered both before and after treatment, including symptoms, TSH levels, and measures of quality of life. Preliminary findings suggest that patients experienced symptomatic relief along with normalization of thyroid function test (TFT) results. The use of Shigru led to notable improvements in clinical symptoms, with TSH levels returning to normal in 7 out of 8 cases. This case series offers encouraging evidence that single drug therapy in Ayurveda can serve as an effective treatment for subclinical hypothyroidism. Additional studies with larger sample sizes and controlled designs are needed to confirm these results and better understand the underlying mechanisms.

Keywords: Subclinical hypothyroidism, Ayurveda, single drug therapy, moringa oleifera, herbal medicine, case series

Corresponding Author How to Cite this Article To Browse
Shubham Dulaji Koundalkar, Assistant Professor, Dept of Dravyaguna, Shri Shivayogeeshwara Rural Ayurvedic Medical College, Inchal, Karnataka, India.
Email:
Koundalkar SD, Chougale A, Dalal D, Efficacy of Single Drug Therapy in the management of Subclinical Hypothyroidism: A Case Series analysis using Ayurvedic approach. J Ayu Int Med Sci. 2025;10(9):377-381.
Available From
https://jaims.in/jaims/article/view/4699/

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2025-07-10 2025-07-20 2025-08-04 2025-08-15 2025-08-28
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Not required 10.62

© 2025by Koundalkar SD, Chougale A, Dalal D and Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Download PDFBack To ArticleIntroductionCase SeriesMaterials and
Methods
ResultsConclusionReferences

Introduction

Subclinical hypothyroidism (SCH) is a disorder characterized by biochemical diagnosis with normal T3 and T4 but increased TSH levels with particular cardinal symptoms.[1] Globally, 3% to 8% of the world population is affected by Subclinical hypothyroidism. It affects 2.4% to 3% male and 6% to 10% females worldwide.[2] The prevalence is found to be high in women as compared to males and it increases with age.[3] Most of the time, the condition Subclinical hypothyroidism is found to be asymptomatic.[4] but can present with symptoms associated with hypothyroidism like weight gain, dry skin, hair loss, loss of appetite, muscular weakness, irregular periods, fatigue, cold intolerance, etc.[5,6] Treatment for SCH if TSH levels >10 mIU/L, recommended by American Thyroid Association (ATA) & American Association of Clinical Endocrinology (AACE) is to begin with levothyroxine therapy.[6] In Ayurveda, there is no direct correlation of SCH, but it can be correlated to Rasa Pradoshaja Vikara[7], Kaphavrita-Udanavata[8], based on clinical manifestations. The Nidana of Rasa Pradoshaja are intake of Atiguru Ahara, Atisnigdha Ahara, and Atimatra Ahara which leads to impairment in Agni, which further hampers the production of rasa.[9] Overtime, this vitiation impairs the quality of rasa dhatu, ultimately disrupting balance of sapta dhatus. The treatment includes Nidanaparivarjana, langhana, shodana chikitsa, shamana chikitsa.

This case series includes 8 cases of Subclinical Hypothyroidism which was well managed with Ayurvedic intervention in terms of Shamana Aushadhis. This intervention was continued for a period of 42 days. The pre and post assessment was based on parameters like weight, BMI, waist circumference and hematological test i.e. Thyroid Function Test (TFT).

Case Series

Patients approaching Thyroid Specialty OPD of our hospital were screened for symptoms of Hypothyroidism, there were total 8 cases of all genders and mid aged group of Subclinical Hypothyroidism, some were pre-diagnosed and some were diagnosed by clinical symptomatically as well as heamatologically. There were number of cases attending OPD for Thyroid

related problems, but typically only 8 cases were selected as they were freshly diagnosed and without pre-existing diseases like DM, HTN etc. and they were ready to take single drug for their existing condition. Proper information of above Ayurvedic approach was explained to all the patients. Consent was taken from all the patients who were willing to be the part of study. Patient information is showed in the following table. (Table 1)

Table 1: Shows Age, Gender, TSH, Weight, waist circumference of patient before study.

Patient ID12345678
Age2444353654484820
GenderFemaleMaleMaleFemaleFemaleMaleFemaleFemale
TSH value5.9814.79.775.736.356.986.9918.2
Weight59.7 kg87 kg57 kg55 kg57 kg67 kg76 kg54 kg
Waist circumference32 inch41.5 inch37.5 inch34 inch36 inch36 inch38 inch31 inch

Clinical Findings

Diagnosis of Thyroid diseases in early stage is very much important as it may evolve to overt clinical Thyroidism or into complicated stage.

Preliminary diagnosis of thyroid disorders start with the case taking by asking signs and symptoms of thyroidism to the patients. If patient is fitting into the diagnosis of thyroidism then Thyroid profile test is to be done for final diagnosis.

Reading Thyroid Profile Test

It contains Thyroid stimulating hormone (TSH), Triiodothyronine (T3), Thyroxine (T4).

  • TSH - Normal range (0.4 - 4.0 mlU/L), though exact range may depending on the lab which method they are using. High TSH levels indicate Hypothyroidism where low TSH indicate Hyperthyroidism.
  • T3 - Normal range (100 - 200 ng/dL), High T3 levels suggests hyperthyroidism, where low T3 shows Hypothyroidism.
  • T4 - Normal range (4.5 - 11.2 µg/dL), High T4 levels indicative of Hyperthyroidism, and low T4 shows hypothyroidism.

There will be elevated TSH but normal T3 & T4 in Subclinical Hypothyroidism.


Materials and Methods

The patients presented with features suggestive of Hypothyroidism were examined; clinical diagnosis was made and then confirmed with the help of Hematological investigation such as Thyroid profile test (TFT). After confirmation, patients with increased TSH value but normal values of T3 & T4 were considered for this case series. The demographic profile, associated symptoms such as weight gain, fatigue, dry skin & hairs, menorrhagia, weight gain, hoarseness of voice, periorbital oedema, bradycardia etc . if presented were taken into consideration for inclusion in this case series. Patients were informed of the objective and effects of their medicine. Patients who accepted to take medicine were prescribed treatment. Intervention period was of 42 days. Outcomes were also analyzed.

Mainly Kapha Dosha and Rasa Dhatu are involved in the pathogenesis of the Hypothyroidism disease. Sheeta Guna (~cold character) of Kapha Dosha is found to be increased in these cases. Hence Kaphahara (~kapha reducing), Ushna Virya (~hot potency) medicines are required. For this case Shigru (Moringa oleifera Linn.) Patra Churna (~powder of leaves) tablet was prepared and used for this case series. Shigru Patra is explained as ‘Medo (~fat of body), Apachi (~enlargement of gland of neck), Gulma (~lump in body), Ganda (~enlargement of thyroid gland), Vrana (~wound), Hareta (conquer)’ in Bhavaprakasha Nighantu. That is why Shigru Patra Churna is selected for this case series.

Table 2: Shows Samprapti Ghataka of disease

Samprapti Ghataka
DoshaKapha
DushyaRasa, Meda
AgniDhatwagni
AmaJatharagnimandhya
SrotasRasavaha Srotas, Annavaha, Medovaha
Sroto DustiSanga
Udbhava SthanaAmashaya
Vyakta SthanaSarva Shareera
AdhisthanaSarva Shareera
RogamargaBahya, Abhyantara, Madhyama

Study Design

Shigru Patra Churna tablet (500 mg each) two

tablets were prescribed to take orally before meal for the duration of 42 days to 8 patients.

Table 3: Showing symptoms of patients before intervention.

Symptoms12345678
Lethargy++--++++
Weakness+++-+--+
Sleepiness+-+-----
Weight gain-+-++-+-
Hair fall----++++

Results

Thyroid profile test was the diagnostic tool which was used for Confirmatory Diagnosis along with clinical diagnosis with help of signs and symptoms. except one patient all the patients reported TFT within normal values. Clinically patients got improvement in most of the Thyroidism complaints. During follow-up of the patients after 1 month; no recurrence was reported clinically.

Table 4: Showing symptoms of patients after intervention

Symptoms12345678
LethargyNN--NNN+
Weakness+N+-+--+
SleepinessN-N-----
Weight gain-+-NN-N-
Hairfall----++++

Table 5: Shows changes in TSH value, Weight and waist circumference of patient after intervention

Patient ID12345678
TSH value3.053.5603.052.874.124.984.3318.2
Weight57.5 kg84 kg55 kg55 kg53 kg64 kg71 kg51 kg
Waist circumference34 inch38.5 inch36 inch34 inch36 inch35 inch37 inch31 inch

Patient with no change in symptoms as well as in TSH value was further advised to check her Anti-TPO it revealed that she had Auto-immune Thyroiditis.

Discussion

A prevalent chronic thyroid gland illness is called hypothyroidism. It is characterized by a lack of thyroid hormones, specifically tri-iodothyronine (T3) and thyroxine (T4), which


predominantly impact energy metabolism. Numerous conditions, including obesity, neurological symptoms, cardiovascular disease, type-2 diabetes mellitus, and infertility, are linked to hypothyroidism. Although the term ‘Hypothyroidism’ is not described in Ayurvedic Samhitas, the condition might be mostly associated with activity of Agni. Ayurvedic texts have described thirteen types of Agni, with the most fundamental being the Jatharagni (~digestive fire present in abdomen). Their equilibrium is contingent upon both Ahara & Vihara.[10]

As was evident in the above instances, habitual eating of Guru, Madhur (~sweet), Sheet, and Drava Ahara (~liquid food article) along with inactivity or less activity, lack of exercise, Shodhana etc. Due to this Kapha Dosha will get vitiated and causes Agnimandya, which leads to formation of Ama, and Dhatwagni Mandyata, resulting into Rasadhatu Vikruti.

Chikitsa (~treatment) for such diseases should focus on Agni, which corrects Dhatwagni Mandhya and Jatharagni. It is necessary for the implementation of Srotorodha (~blockage of channels), Kapha-Vata Shaman, and Medohara (~reducing fat) line of treatment.

Shigru Patra has Katu, Tikta Rasa, Ushna Virya, Katu Vipaka and Kapha-Vata Hara Karma; which will help for Agni Deepana and Shoshana when administration done on empty stomach. The word Shigru itself says ‘Shinoti Taikshnyat Shigru’ which means drug which possess Tikshnata. One more synonym is Mochaka which says ‘Munchati Rogat Mochak’ means which eradicates all diseases.

Katu Rasa has ‘Sneha-Meda-Kleda Shoshana’ Guna[11] which is helpful in such cases where in obesity due to Hypothyroidism there will be accumulation of excessive subcutaneous fat is seen. Also Shigru acts as Apatarpanakara due to it’s Ruksha, Ushna and Laghu Guna. Katu Rasa also does Srotomukha Shodhana which is very much useful in such cases.

Glucosinolate, quercetin & glucomoringin are some of the phytochemicals present in Moringa leaf which has anti-inflammatory property. Kaempferol is one more phytochemical which is strong antioxidant which helps in regulation of oxidative stress, which is one of the factor for progression of mild to severe form.[12]

Conclusion

This case series emphasizes the promise of single drug therapy in Ayurveda, particularly the application of Shigru, as an effective strategy for addressing subclinical hypothyroidism. The results indicate notable clinical improvements and normalization of thyroid function tests in most patients. Considering the holistic nature of Ayurveda, this approach may serve as a complementary treatment alongside traditional therapy. To enhance the credibility of these findings, it is crucial to conduct further research with larger sample sizes and more robust study designs. Such studies will help confirm these initial results and provide greater insights into how Ayurvedic treatments influence thyroid health. Shigru Patra can be considered as one of the promising drug in treatment of Hypothyroidism.

References

1. Fauci AS, Kasper DL, Braunwald E, Hauser SL, Loscalzo J. Harrison’s Principles of Internal Medicine. 17th ed. Vol II. New York: McGraw-Hill; 2008. p. 2233 [Crossref][PubMed][Google Scholar]

2. Waghmare GA. Ayurvedic management of subclinical hypothyroidism – a case report. J Endocrinol Thyroid Res. 2018;3(4):555617. doi:10.19080/JETR.2018.03.555617 [Crossref][PubMed][Google Scholar]

3. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489–99. doi:10.1210/jcem.87.2.8182 [Crossref][PubMed][Google Scholar]

4. Peeters RP. Subclinical hypothyroidism. N Engl J Med. 2017 Jun 29;376(26):2556–65. [Crossref][PubMed][Google Scholar]

5. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022 May 19;8(1):30. [Crossref][PubMed][Google Scholar]


6. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012 Nov-Dec;18(6):988–1028. [Crossref][PubMed][Google Scholar]

7. Agnivesha. Charaka Samhita. Ayurveda Deepika commentary by Chakrapani Datta. Sutra Sthana, Ch. 28, Ver.9–10. New Delhi: Chaukhambha Publications; 2016. p.179 [Crossref][PubMed][Google Scholar]

8. Agnivesha. Charaka Samhita. Ayurveda Deepika commentary by Chakrapani Datta. Varanasi: Chaukhamba Surbharati Prakashan; 2013. Vimanasthana Ch.5, Ver.13. p.251 [Crossref][PubMed][Google Scholar]

9. Vedavati, Belavadi SN. Ayurvedic management of subclinical hypothyroidism vis-à-vis Kaphavrita Udanavata – a case report. J Ayurveda Hol Med. 2023;11(6):89–94. [Crossref][PubMed][Google Scholar]

10. Kushwah H, Mishra S. Grahani Dosha Chikitsa. In: Charaka Samhita of Agnivesha, Chikitsa Sthana, Ch. 15, Ver. 39–40. Varanasi: Chaukhambha Orientalia; Reprint 2017 [Crossref][PubMed][Google Scholar]

11. Tripathi B. Rasabhediya Adhyaya. In: Astanga Hridaya of Vagbhata, Sutra Sthana, Ch. 10, Ver. 17–18. Delhi: Chaukhambha Sanskrit Pratishthan; Reprint 2022 [Crossref][PubMed][Google Scholar]

12. Kochman J, Jakubczyk K, Bargiel P, Janda-Milczarek K. The influence of oxidative stress on thyroid diseases. Antioxidants (Basel). 2021 Sep 10;10(9):1442. doi:10.3390/antiox10091442. PMID: 34573074; PMCID: PMC8465820 [Crossref][PubMed][Google Scholar]

Disclaimer / Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.